M K Proteins share price & results
- Jun 2026
- Jun 2026
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 115 | +0.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 2.2 | −2.6 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 1.4 | −60.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
| Return on equity | 6.39 | −2.1 pts | Trailing twelve months | TTM to Jun 2026 | Adjusted profit attributable to owners ÷ average owners’ equity. |
| Free cash flow margin | 0.84 | +7.6 pts | Fiscal year | FY ending Mar 2026 | (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue. |
| Revenue growth (YoY) | 17.76 | +33.5 pts | Trailing twelve months | TTM to Jun 2026 | Revenue change against the same period one year earlier. |
Price
Performance −45.0% 1Y
1Y: ₹6.82 on 24 Oct 2025 → ₹3.75. High ₹6.82 (24 Oct 2025), low ₹3.7 (26 Oct 2026).
- Previous close
- ₹3.7
- Market cap
- ₹144 Cr
- 52-week range
- ₹3.7 – ₹6.81
- One year
- −43.78%
- Price to earnings (TTM to Jun 2026)
- 30.64×
- Return on equity (TTM to Jun 2026)
- 6.39%
Overview
- Symbol
- NSE:MKPL
- Exchange
- NSE
- Currency
- INR
Fundamentals
Ratios, each with its period
Current values with the period they cover; the trend reads across the 6 fiscal years held (Mar 2021 to Mar 2026).
Financials
What the filings say
Net profit, year on year: −61% (quarter to jun 2026 against jun 2025).
| Line item | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 34 | 39 | 137 | 115 | 32 | 90 | 146 | 115 |
| Expenses | 31 | 38 | 133 | 109 | 31 | 87 | 143 | 113 |
| Operating profit | 2 | 2 | 5 | 6 | 1 | 2 | 3 | 3 |
| Operating margin | 6.6% | 4.5% | 3.4% | 4.8% | 3.2% | 2.6% | 1.7% | 2.2% |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 2 | 2 | 4 | 5 | 1 | 2 | 2 | 2 |
| Tax rate | 25.2% | 25.8% | 28.6% | 25.3% | 25.3% | 26.9% | 33.7% | 25.4% |
| Net profit | 2 | 1 | 3 | 4 | 1 | 1 | 1 | 1 |
| EPS (₹ per share) | 0.05 | 0.04 | 0.07 | 0.09 | 0.02 | 0.04 | 0.03 | 0.04 |
| Line item | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 246 | 268 | 383 |
| Expenses | 229 | 255 | 371 |
| Operating profit | 17 | 12 | 11 |
| Other income | 0 | 0 | 0 |
| Interest | 1 | 1 | 2 |
| Depreciation | 1 | 0 | 0 |
| Profit before tax | 15 | 11 | 9 |
| Net profit | 11 | 8 | 7 |
| Line item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 4 | 13 | 38 | 38 | 38 | 38 |
| Reserves | 35 | 37 | 24 | 32 | 36 | 39 |
| Borrowings | 37 | 46 | 20 | 39 | 2 | 37 |
| Other liabilities | 10 | 8 | 15 | 22 | 4 | 18 |
| Total liabilities | 86 | 103 | 96 | 131 | 80 | 131 |
| Fixed assets | 3 | 3 | 3 | 4 | 3 | 5 |
| Capital work in progress | 0 | 0 | 6 | 7 | 7 | 7 |
| Investments | 0 | 0 | 0 | 0 | 4 | 0 |
| Other assets | 83 | 100 | 88 | 120 | 66 | 119 |
| Total assets | 86 | 103 | 96 | 131 | 80 | 131 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 6 | -10 | -6 | 32 | -16 | 5 |
| Cash from investing | 0 | -2 | 0 | -6 | -1 | -2 |
| Cash from financing | -5 | 12 | 6 | -27 | 18 | -3 |
| Net cash flow | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | 5 | -12 | -6 | 27 | -18 | 4 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor days | 24 | 42 | 19 | 5 | 2 | 2 |
| Inventory days | 48 | 80 | 91 | 134 | 170 | 114 |
| Days payable | 10 | 8 | 6 | 19 | 29 | 5 |
| Cash conversion cycle | 62 | 114 | 104 | 120 | 142 | 110 |
| Working capital days | 36 | 55 | 57 | 77 | 81 | 62 |
| Return on capital employed | 29.0% | 23.0% | 20.0% | 19.0% | 13.0% | 10.0% |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
What the price assumes
Growth trapTo justify its price of ₹4, this stock must grow earnings at 21% every year for 7 years. Our analysis caps realistic growth at ~-24%. At that growth it is worth ₹0 — downside of 91%.
- Growth the price implies
- 20.9% a year
- for 7 years, fading to 4%
- It has actually compounded at
- -21.7% a year
- net profit, FY24–FY26 · EPS -23.6%
- The gap
- 0.4 pp
- -91% downside if it only repeats history
Ownership
Who owns it
Promoters hold 74.82% as of Jun 2026; institutions added 0.00 pts since Mar 2026.
- Promoters 74.82%
- Foreign institutions 0.00%
- Public 25.18%
Who is on the register
Named in the Jun 2026 filing
Every holder of M K Proteins Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| 6.33% | unchanged | |
| 6.23% | unchanged | |
| 6.19% | unchanged | |
| 6.11% | unchanged | |
| 5.71% | unchanged | |
| 5.61% | unchanged | |
| 4.65% | unchanged | |
| 4.33% | unchanged | |
| 4.27% | unchanged | |
| 4.20% | unchanged | |
| 3.89% | unchanged | |
| 3.89% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Your own record
Start an Inve Case for M K Proteins Limited
Free account: one company. Everything above stays public.
Write why you follow M K Proteins Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other Fast Moving Consumer Goods companies
Learn to analyse M K Proteins Limited
Guides on how to read this kind of business and the numbers that matter.